Literature DB >> 15060529

AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome.

Neil Ruderman1, Marc Prentki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15060529     DOI： 10.1038/nrd1344

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  133 in total

Review 1.  Cancer cell signaling pathways targeted by spice-derived nutraceuticals.

Authors:  Bokyung Sung; Sahdeo Prasad; Vivek R Yadav; Bharat B Aggarwal
Journal:  Nutr Cancer       Date:  2011-12-09       Impact factor: 2.900

2.  Simultaneous changes in high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis and those underlying molecular mechanisms in novel SHRSP5/Dmcr rat.

Authors:  Takashi Moriya; Kazuya Kitamori; Hisao Naito; Yukie Yanagiba; Yuki Ito; Nozomi Yamagishi; Hazuki Tamada; Xiaofang Jia; Satoru Tsuchikura; Katsumi Ikeda; Yukio Yamori; Tamie Nakajima
Journal:  Environ Health Prev Med       Date:  2012-03-11       Impact factor: 3.674

Review 3.  Insulin resistance due to nutrient excess: is it a consequence of AMPK downregulation?

Authors:  Asish K Saha; X Julia Xu; Thomas W Balon; Amanda Brandon; Edward W Kraegen; Neil B Ruderman
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

Review 4.  Islet beta cell failure in type 2 diabetes.

Authors:  Marc Prentki; Christopher J Nolan
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

Review 5.  The metabolic syndrome and the heart--a considered opinion.

Authors:  J G Leichman; V R Lavis; D Aguilar; C R Wilson; H Taegtmeyer
Journal:  Clin Res Cardiol       Date:  2006-01       Impact factor: 5.460

6.  Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease.

Authors:  Zhao-Xia Yang; Wei Shen; Hang Sun
Journal:  Hepatol Int       Date:  2010-08-12       Impact factor: 6.047

Review 7.  Glucolipotoxicity: fuel excess and beta-cell dysfunction.

Authors:  Vincent Poitout; R Paul Robertson
Journal:  Endocr Rev       Date:  2007-11-29       Impact factor: 19.871

8.  Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition.

Authors:  X Yu; S McCorkle; M Wang; Y Lee; J Li; A K Saha; R H Unger; N B Ruderman
Journal:  Diabetologia       Date:  2004-12-02       Impact factor: 10.122

9.  Inhibition of ABCA1 protein degradation promotes HDL cholesterol efflux capacity and RCT and reduces atherosclerosis in mice.

Authors:  LinZhang Huang; BaoYan Fan; Ang Ma; Philip W Shaul; HaiBo Zhu
Journal:  J Lipid Res       Date:  2015-03-11       Impact factor: 5.922

10.  Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop.

Authors:  Sridevi Devaraj; Natalie Torok; Mohan R Dasu; David Samols; Ishwarlal Jialal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-01       Impact factor: 8.311
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.